CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 82 filers reported holding CATALYST BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,665 | +430.4% | 49,066 | +127.6% | 0.00% | – |
Q1 2023 | $4,462 | -97.4% | 21,555 | -93.3% | 0.00% | – |
Q4 2022 | $169,811 | +76.9% | 321,916 | +68.7% | 0.00% | – |
Q3 2022 | $96,000 | -81.1% | 190,797 | -33.0% | 0.00% | – |
Q2 2022 | $507,000 | +496.5% | 284,580 | +120.9% | 0.00% | – |
Q1 2022 | $85,000 | -70.5% | 128,800 | -59.0% | 0.00% | – |
Q4 2021 | $288,000 | -83.0% | 314,416 | -23.6% | 0.00% | – |
Q3 2021 | $1,690,000 | +622.2% | 411,309 | +660.3% | 0.00% | – |
Q2 2021 | $234,000 | -22.5% | 54,100 | -9.7% | 0.00% | – |
Q1 2021 | $302,000 | -39.6% | 59,900 | -24.4% | 0.00% | – |
Q4 2020 | $500,000 | +275.9% | 79,220 | +156.2% | 0.00% | – |
Q3 2020 | $133,000 | -95.2% | 30,921 | -93.4% | 0.00% | -100.0% |
Q2 2020 | $2,750,000 | -9.4% | 468,262 | -32.6% | 0.00% | 0.0% |
Q1 2020 | $3,035,000 | +15.0% | 694,642 | +79.2% | 0.00% | 0.0% |
Q4 2019 | $2,640,000 | +81.8% | 387,682 | +31.1% | 0.00% | 0.0% |
Q3 2019 | $1,452,000 | +204.4% | 295,815 | +356.8% | 0.00% | – |
Q2 2019 | $477,000 | -3.8% | 64,764 | +6.1% | 0.00% | – |
Q1 2019 | $496,000 | -15.6% | 61,065 | -18.1% | 0.00% | – |
Q4 2018 | $588,000 | -33.9% | 74,531 | -9.8% | 0.00% | – |
Q3 2018 | $890,000 | -13.3% | 82,612 | -6.1% | 0.00% | – |
Q2 2018 | $1,027,000 | +229.2% | 88,019 | +627.4% | 0.00% | – |
Q1 2018 | $312,000 | – | 12,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |